Literature DB >> 31570373

PTEN in Chromatin Remodeling.

Jingyi Yang1, Yuxin Yin1,2.   

Abstract

The tumor suppressor phosphatase and tension homolog (PTEN) is frequently mutated in human cancers, and it functions in multiple ways to safeguard cells from tumorigenesis. In the cytoplasm, PTEN antagonizes the PI3K/AKT pathway and suppresses cellular proliferation and survival. In the nucleus, PTEN is indispensable for the maintenance of genomic stability. In addition, PTEN loss leads to extensive changes in gene expression at the transcriptional level. The linker histone H1, generally considered as a transcriptional repressor, binds to the nucleosome to form a structure named the chromatosome. The dynamics between H1 and chromatin play an important role in determining gene expression. Here, we summarize the current understanding of roles of PTEN in controlling chromatin dynamics and global gene expression, which is crucial function of nuclear PTEN. We will also introduce the recent discovery of the PTEN family members and their functions.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31570373      PMCID: PMC6996446          DOI: 10.1101/cshperspect.a036160

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  69 in total

Review 1.  The biology of chromatin remodeling complexes.

Authors:  Cedric R Clapier; Bradley R Cairns
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

2.  Roles of H1 domains in determining higher order chromatin structure and H1 location.

Authors:  J Allan; T Mitchell; N Harborne; L Bohm; C Crane-Robinson
Journal:  J Mol Biol       Date:  1986-02-20       Impact factor: 5.469

3.  PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin.

Authors:  Gang Li; Yingchun Hu; Yanying Huo; Minli Liu; Dan Freeman; Jing Gao; Xin Liu; De-Chang Wu; Hong Wu
Journal:  J Biol Chem       Date:  2006-02-28       Impact factor: 5.157

4.  Crystal structure of globular domain of histone H5 and its implications for nucleosome binding.

Authors:  V Ramakrishnan; J T Finch; V Graziano; P L Lee; R M Sweet
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

5.  Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure.

Authors:  Lili Gong; Jeane M Govan; Elizabeth B Evans; Hui Dai; Edward Wang; Szu-Wei Lee; Hui-Kuan Lin; Alexander J Lazar; Gordon B Mills; Shiaw-Yih Lin
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.

Authors:  Jason D Buenrostro; Paul G Giresi; Lisa C Zaba; Howard Y Chang; William J Greenleaf
Journal:  Nat Methods       Date:  2013-10-06       Impact factor: 28.547

7.  Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.

Authors:  Nils Wethkamp; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

8.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

Review 9.  PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation.

Authors:  Sheng-Qi Hou; Meng Ouyang; Andrew Brandmaier; Hongbo Hao; Wen H Shen
Journal:  Bioessays       Date:  2017-09-11       Impact factor: 4.345

Review 10.  The molecular hallmarks of epigenetic control.

Authors:  C David Allis; Thomas Jenuwein
Journal:  Nat Rev Genet       Date:  2016-06-27       Impact factor: 53.242

View more
  5 in total

Review 1.  The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers.

Authors:  Qinyi Wang; Junmin Wang; Hongjiao Xiang; Peilun Ding; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 2.  PTEN in Hereditary and Sporadic Cancer.

Authors:  Joanne Ngeow; Charis Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

3.  A-FABP-PTEN/AKT Regulates Insulin Resistance in Preadipocyte Cell 3T3-L1 Cells.

Authors:  Rensiqin Wu; Hui Wang; Jian Huangfu; Rui Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-11       Impact factor: 3.168

Review 4.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

Review 5.  Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Authors:  Xiaonan Zhang; Tobias Sjöblom
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.